Michael Kishko completed his PhD at the Morningside Graduate School of Biomedical Sciences at the University of Massachusetts, USA, in 2011. He is a Principal Scientist with Sanofi Pasteur, based in Massachusetts, USA, where he performs vaccine discovery for respiratory viruses. He has made numerous contributions to vaccine research and development, and is the author of numerous publications in international scientific journals.